Special Issue "New Perspectives in the Treatment of Non-melanoma Skin Cancer"
Deadline for manuscript submissions: closed (15 February 2021).
Interests: melanoma; non-melanoma skin cancer; cancerization field; chemoprevention
Non-melanoma skin cancers (NMSC) are the most common malignancy in humans, with a higher incidence in chronically immunosuppressed patients. BCCs can cause significant local tissue destruction and disfigurement, whereas in SCCs, there is a not-insignificant risk of recurrence and metastasis. The goal of the treatment is the complete eradication of the tumor while preserving important functionally and aesthetically anatomical structures. Surgical approaches demonstrate a cure rate greater than 90% when appropriate treatment is applied based on the characteristics of the primary tumor and patient. However, many other treatment modalities have been suggested. In selected cases, medical topical treatments can provide a high chance of cure, with generally excellent cosmetic outcomes.
Moreover, in advanced and metastatic NMSCs, recently developed molecularly targeted therapy and immunological checkpoint inhibitory can represent a reasonably promising alternative.
The purpose of this Special Issue is to discuss all therapeutic approaches of NMSCs, giving information about their mechanisms of action, indications, efficacy, side effects, and contraindications.
Prof. Paola Savoia
Dr. Elisa Zavattaro
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Non-melanoma skin cancer
- Skin tumor treatment
- Basal cell carcinoma
- Squamous cell carcinoma
- Systemic therapy in NMSC
- Topical treatment of NMSC
- Non-surgical treatment of cutaneous tumors